Rekombinanter IL6 (Siltuximab Biosimilar) Antikörper
Research Grade
Reaktivität: Human
ELISA
Wirt: Mammalian Cells
Monoclonal
unconjugated
Recombinant Antibody
-
- Target Alle IL6 (Siltuximab Biosimilar) Produkte
- IL6 (Siltuximab Biosimilar)
- Antikörpertyp
- Recombinant Antibody
- Reaktivität
- Human
-
Wirt
-
Mammalian Cells
- Expressionssystem
- Mammalian cells
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser IL6 (Siltuximab Biosimilar) Antikörper ist unkonjugiert
-
Applikation
- ELISA
- Verwendungszweck
- Siltuximab Biosimilar - Anti-IL6 mAb
- Produktmerkmale
- Antibody Type: IgG1Kappa
- Aufreinigung
- Recombinant antibody expressed in mammalien cells and purified.
- Güteklasse
- Research Grade
- Isotyp
- IgG1 kappa
-
anti-IL6 (Siltuximab Biosimilar) antibody
Research Grade Reaktivität: Human ELISA, FACS Wirt: Maus Chimeric unconjugated Recombinant Antibody
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- PBS pH 7.5
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- 4°C for short term, -20°C for long term
-
- Target
- IL6 (Siltuximab Biosimilar)
- Abstract
- IL6 (Siltuximab Biosimilar) Produkte
- Substanzklasse
- Biosimilar
- Hintergrund
-
Siltuximab
The Siltuximab antibody is a chimeric mouse/human therapeutic antibody obtained from mouse hybridoma. It is one of several IgG1 antibodies known to bind the human interleukin 6 (IL-6) molecule, a soluble glycoprotein with a key role in pro-inflammatory responses. IL-6 is one of the main proinflammatory cytokines overexpressed in multiple pathologies (e.g. viral infections, rheumatoid arthritis, MCD, etc.).
-
Sie sind hier:
